Pharmaceuticals Company Reports & Industry Analysis
If you’re searching for objective information on top pharmaceutical companies—including emerging and established players—look no further. MarketResearch.com offers a vast collection of reports that provide detailed insights into a company’s organizational structure and key offerings within the pharmaceutical industry. These reports are valuable resources for identifying potential clients and partners, as well as gaining a deeper understanding of the strengths and weaknesses of competitors.
Pharmaceutical Company Profiles
- Access financial analysis, strategic assessments, SWOT analyses, and information on collaboration and licensing deals.
- Gain expert insights on prominent competitors such as Pfizer, Roche, Merck, AstraZeneca, Sanofi, Eli Lilly, and more.
- Browse reports from various research firms such as GlobalData, MarketLine, Current Partnering, Plunkett Research, and many others.
A Reliable Source for Research
Our pharmaceutical company reports provide you with crucial data and insights from leading market research firms around the world. Whether you are conducting due diligence, or looking to expand into new markets, our research delivers the strategic intelligence needed for success. For decades, organizations across the value chain have chosen us as their trusted partner. Browse our reports today for unmatched value and convenience.
Pharmaceuticals Company Reports Industry Research & Market Reports
-
Novavax, Inc. - Company Profile and SWOT Analysis
... product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Novavax, Inc. (Novavax or ‘the company’) is a biotechnology company that discovers, develops and markets vaccines for the prevention ... Read More
-
Astellas Pharma Inc. - Company Profile and SWOT Analysis
... SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Astellas Pharma Inc. (Astellas or ‘the company’) manufactures, markets, develops, import and export of pharmaceuticals and related ... Read More
-
Pharma M&A Deals 2023 - Top Themes - Thematic Research
... deals worth $233 billion, a growth of 81% compared to 2022. In terms of deal volume also, there was a growth of 14% to record 937 M&A deals in 2023. Pharma sector recorded 46 mega ... Read More
-
Vertex Pharmaceuticals Incorporated - Company Profile and SWOT Analysis
... SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Vertex Pharmaceuticals Incorporated (Vertex or “the company”) involved in the discovery, development and commercialization of new medicines. ... Read More
-
Boiron SA - Company Profile and SWOT Analysis
... product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Boiron SA (Boiron or 'the company') manufactures, markets and distributes homeopathic medicines. The company’s product portfolio includes Camilia, Arnigel, ... Read More
-
Hikma Pharmaceuticals PLC - Company Profile and SWOT Analysis
... SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Hikma Pharmaceuticals PLC (Hikma or 'the company') is a developer, manufacturer and marketer of generic and in-licensed ... Read More
-
Sandoz International GmbH - Company Profile and SWOT Analysis
... SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Sandoz International GmbH (Sandoz or ‘the company’), a subsidiary of Novartis AG, is engaged in the development, ... Read More
-
Dr. Reddy's Laboratories Limited - Company Profile and SWOT Analysis
... structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Dr. Reddy's Laboratories Limited (DRL or 'the company') is a manufacturer of generics, active pharmaceutical ... Read More
-
H. Lundbeck A/S - Company Profile and SWOT Analysis
... SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights H. Lundbeck A/S (Lundbeck or 'the company') is engaged in research, development, production and sale of pharmaceuticals ... Read More
-
Ionis Pharmaceuticals, Inc. - Company Profile and SWOT Analysis
... SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Ionis Pharmaceuticals, Inc. (Ionis or ‘the company’) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. ... Read More
-
Mitsubishi Tanabe Pharma Corporation - Company Profile and SWOT Analysis
... structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Mitsubishi Tanabe Pharma Corporation (Mitsubishi Tanabe or 'the company'), a subsidiary of Mitsubishi Chemical Holdings ... Read More
-
Almirall S.A. - Company Profile and SWOT Analysis
... product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Almirall S.A. (Almirall or 'the company) develops, manufactures, and markets licensed and proprietary drugs. The company develops products in ... Read More
-
Cassava Sciences Inc - Company Profile and SWOT Analysis
... SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Cassava Sciences Inc (Cassava Sciences or ‘the company’), formerly known as Pain Therapeutics Inc, is a developer ... Read More
-
EyePoint Pharmaceuticals (EYPT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Findings. This unique new report provides deep financial benchmarks for EyePoint Pharmaceuticals (EYPT:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for EyePoint ... Read More
-
Collegium Pharmaceutical Inc (COLL:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry. Key Findings. This unique new report provides deep financial benchmarks for Collegium Pharmaceutical Inc (COLL:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking ... Read More
-
NovaBay Pharmaceuticals Inc (NBY:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry. Key Findings. This unique new report provides deep financial benchmarks for NovaBay Pharmaceuticals Inc (NBY:ASE) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking ... Read More
-
BioCryst Pharmaceuticals Inc (BCRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry. Key Findings. This unique new report provides deep financial benchmarks for BioCryst Pharmaceuticals Inc (BCRX:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking ... Read More
-
CTI BioPharma Corp (CTIC:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry. Key Findings. This unique new report provides deep financial benchmarks for CTI BioPharma Corp (CTIC:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking ... Read More
-
Elite Pharmaceuticals Inc (ELTP:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry. Key Findings. This unique new report provides deep financial benchmarks for Elite Pharmaceuticals Inc (ELTP:PINX) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking ... Read More
-
Syros Pharmaceuticals (SYRS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Findings. This unique new report provides deep financial benchmarks for Syros Pharmaceuticals (SYRS:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for Syros ... Read More
-
Ironwood Pharmaceuticals Inc (IRWD:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry. Key Findings. This unique new report provides deep financial benchmarks for Ironwood Pharmaceuticals Inc (IRWD:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking ... Read More
-
MiMedx Group Inc (MDXG:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry. Key Findings. This unique new report provides deep financial benchmarks for MiMedx Group Inc (MDXG:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking ... Read More
-
Reata Pharmaceuticals (RETA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Findings. This unique new report provides deep financial benchmarks for Reata Pharmaceuticals (RETA:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for Reata ... Read More
-
AbbVie Inc (ABBV:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Findings. This unique new report provides deep financial benchmarks for AbbVie Inc (ABBV:NYS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for AbbVie ... Read More
-
Durect Corporation (DRRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Findings. This unique new report provides deep financial benchmarks for Durect Corporation (DRRX:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for Durect ... Read More
Research Assistance
